BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12321843)

  • 1. No over-the-counter OCs, say family planners.
    Contracept Technol Update; 1998 Oct; 19(10):128. PubMed ID: 12321843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pill won't budge from no. 1 spot: half of women leave exams with OCs.
    Contracept Technol Update; 2000 Sep; 21(9):101-4. PubMed ID: 12296239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young teens are safe on pills but need counseling, follow-up.
    Contracept Technol Update; 1987 Sep; 8(9):120-2. PubMed ID: 12268914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency contraception: not a secret any more.
    Contracept Technol Update; 1998 Oct; 19(10):136-8. PubMed ID: 12321845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pills remain the top choice among reversible contraceptive options.
    Contracept Technol Update; 1999 Sep; 20(9):97-101. PubMed ID: 12290380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providers make EC readily available.
    Contracept Technol Update; 2000 Sep; 21(9):112-3. PubMed ID: 12296244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should oral contraceptives be sold over-the-counter?
    Stone SC
    Am J Gynecol Health; 1993; 7(2):27-32. PubMed ID: 12319537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pill power: oral contraceptives hold top spot in family planning arsenal.
    Contracept Technol Update; 1998 Oct; 19(10):125-7. PubMed ID: 12321842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On 7/7/7 preferred for new patients by 47% of respondents.
    Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experts debate pill switching to combat noncompliance. Special report: annual pill survey.
    Contracept Technol Update; 1992 Oct; 13(10):149-53. PubMed ID: 12344722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches vary in managing the over-40 pill patient.
    Contracept Technol Update; 1988 Sep; 9(9):105-7. PubMed ID: 12342192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most providers comfortable giving OCs to women over age 40. Special report: annual pill survey.
    Contracept Technol Update; 1992 Oct; 13(10):158-9. PubMed ID: 12344725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatrically impaired patients often exposed to pregnancy risk.
    Neinstein LS; Katz B
    Contracept Technol Update; 1985 Jun; 6(6):88-90. PubMed ID: 12313658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of data on morning after pill confounds clinicians.
    Contracept Technol Update; 1987 Nov; 8(11):137-40. PubMed ID: 12269058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examine use of low- and lower-dose OCs.
    Contracept Technol Update; 2000 Jun; 21(6):72-3. PubMed ID: 12295925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Might generic OCs create contraceptive price war?
    Contracept Technol Update; 1987 Feb; 8(2):13-7. PubMed ID: 12314977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to use OCs? Readers offer insights.
    Contracept Technol Update; 1999 Sep; 20(9):105-6. PubMed ID: 12290377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experts recommend ways to combat noncompliance. Special report: annual pill survey.
    Contracept Technol Update; 1992 Oct; 13(10):156-8. PubMed ID: 12344724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised oral contraceptive labeling: FDA approves recommendation allowing delay of pelvic exam.
    Contracept Rep; 1993 Nov; 4(5):4-7. PubMed ID: 12287403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norplant insertions, removals remain low.
    Contracept Technol Update; 2000 Sep; 21(9):105. PubMed ID: 12296240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.